In line with this, publicly available data from the TCGA Research Network (https://www.cancer.gov/tcga) for ovarian cancer demonstrated that patients with FIGO III or IV ovarian cancer display a trend of decreased FLYWCH1 expression compared to patients with FIGO II tumours (Supplementary Fig. S2B). This evidence concerns the gene FLYWCH1 and neoplasm.